Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Sunday, September 27

5:00 PM - 6:00 PM ET

From Trials to Real-World Impact
Speaker: Luh, Join, MD, FASTRO - St. Joseph Hospital, Eureka, California
5:00 PM - 6:00 PM ET

From Trials to Real-World Impact
Speaker: Nead, Kevin, MD, MPhil - The University of Texas MD Anderson Cancer Center, Houston, TX
5:00 PM - 5:05 PM ET

Introduction
Speaker: Brady, Jessica, MD, MB, ChB - Guy's and St Thomas' NHS Trust, London, London
5:00 PM - 6:00 PM ET

Kidneys, Bladders, and Breakthroughs
Speaker: Eldredge-Hindy, Harriet, MD - Medical University of South Carolina, Charleston, SC
5:00 PM - 6:00 PM ET

Kidneys, Bladders, and Breakthroughs
Speaker: Ray, Amitabh, MD, MBBS, DNB - Chittaranjan National Cancer Institute, Kolkata, West Benga
5:05 PM - 5:10 PM ET

1020 - Prospective Study of Surface Guided Radiation Therapy (SGRT) Alone or in Combination with Fiducials for Free Breathing (FB) vs. Breath Hold (BH) Stereotactic Body Radiation Therapy (SBRT) Treatments of the Lung
Speaker: Heinzerling, John, MD - Atrium Health Levine Cancer, Wake Forest School of Medicine, Southeast Radiation Oncology Group PA, Charlotte, NC
5:05 PM - 5:10 PM ET

1084 - Solitary Plasmacytoma Treated by Lenalidomide and Dexamethasone in Combination with Radiation Therapy: Long Term Clinical Outcomes
Speaker: Kirova, Youlia, MD - Institut Curie, Paris, Paris
5:10 PM - 5:15 PM ET

1021 - Adebrelimab as Maintenance Therapy Following Hyperfractionated Simultaneous Integrated Boost Radiotherapy Plus Chemotherapy in Limited-Stage Small-Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Phase II Trial
Speaker: Yu, Jiayi, MD, PhD - Peking University Cancer Hospital and Institute, Beijing, Beijing
5:10 PM - 5:15 PM ET

1085 - A Phase II Single-arm Study of Total Body Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) Total Body Irradiation (TBI)
Speaker: Shaikh, Fauzia, MD - NYU Langone Health- Radiation Oncology, New York, NY
5:10 PM - 5:20 PM ET

133 - Efficacy and Safety of Targeted-Immunotherapy with or without Stereotactic Ablative Radiotherapy for Recurrent/Metastatic Renal Cell Carcinoma: The Result of a Multicenter Ambidirectional cohort study
Speaker: Hu, Ke, MD - Peking University First Hospital, Beijing, Beijing
5:10 PM - 5:20 PM ET

139 - Characterization of Laboratory Eligibility Criteria In Phase III Oncology Trials: A Meta-Epidemiological Analysis
Speaker: Pocha, Olivia, MS, BS - Tulane University School of Medicine, New Orleans, LA
5:10 PM - 5:20 PM ET

144 - Single-CT Simulation for Surface-Guided DIBH Radiotherapy Using Deep Learning-Synthesized 3D Body Contours from Scout Images
Speaker: Lee, Inbum, PhD - Seoul National University Hospital, Seoul, SEO